Difference between revisions of "Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2) (Q10988)"
Jump to navigation
Jump to search
(Created claim: Has Sectioning (P146): Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2) (Q10986), #quickstatements; #temporary_batch_1592927655947) |
(Created claim: Has Sectioning (P146): Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) (Q10987), #quickstatements; #temporary_batch_1592927655947) |
||
| Property / Has Sectioning | |||
| + | |||
| Property / Has Sectioning: Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) / rank | |||
| + | Normal rank | ||
Revision as of 15:54, 23 June 2020
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2)
|
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
|
